New era in oncology signals hope in pancreatic cancer
The news of daraxonrasib's success is a scientific breakthrough and just the beginning of a new era of RAS inhibitors.
Posts tagged as
ASCO26
Large national study finds outstanding early outcomes with proton and photon therapy for prostate cancer
A large national clinical trial funded by the Patient-Centered Outcomes Research Institute (PCORI) has shown outstanding early outcomes for prostate cancer patients treated with both proton therapy and standard photon radiation therapy. Nancy Mendenhall, M.D. Nancy Mendenhall, M.D., medical director of the UF Health Proton Therapy Institute,…
Novel liquid biopsy test shows promise in monitoring treatment response for GI cancers
An ultra-sensitive liquid biopsy test that assesses DNA shed by tumors in the bloodstream may help doctors better monitor how patients with advanced GI cancers respond to treatment.
UF Health Cancer Institute at 2026 ASCO Annual Meeting
The UF Health Cancer Institute will showcase the breadth of its innovative research at the 2026 ASCO Annual Meeting.
